BeiGene
BGNE
#967
Rank
A$31.94 B
Marketcap
$292.02
Share price
0.49%
Change (1 day)
9.67%
Change (1 year)
BeiGene is a Chinese pharmaceutical company engaged in the R&D, and commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

We have found no dividend yield history for this company